AMENDED AND RESTATED COMMON STOCK PURCHASE AGREEMENT by and between CYCLERION THERAPEUTICS, INC., and THE INVESTORS NAMED HEREIN Dated as of February 25, 2019Common Stock Purchase Agreement • March 4th, 2019 • Cyclerion Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 4th, 2019 Company Industry JurisdictionThis AMENDED AND RESTATED COMMON STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of February 25, 2019, is entered into by and between Cyclerion Therapeutics, Inc., a Massachusetts corporation (the “Company”), and the Persons named on the signature pages hereto under the heading “Investors”, including those Persons who become parties to this Agreement after the date hereof as “Investors” by signing a Joinder (as defined below) pursuant to Section 1.2 (together, the “Investors”). Certain terms used and not otherwise defined in the text of this Agreement are defined in Section 9 hereof.
COMMON STOCK PURCHASE AGREEMENT by and between CYCLERION THERAPEUTICS, INC., and THE INVESTORS NAMED HEREIN Dated as of January 7, 2019Common Stock Purchase Agreement • January 28th, 2019 • Cyclerion Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledJanuary 28th, 2019 Company Industry JurisdictionThis COMMON STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of January 7, 2019, is entered into by and between Cyclerion Therapeutics, Inc., a Massachusetts corporation (the “Company”), and the Persons named on the signature pages hereto under the heading “Investors”, including those Persons who become parties to this Agreement after the date hereof as “Investors” by signing a counterpart signature page hereto pursuant to Section 1.2 (together, the “Investors”). Certain terms used and not otherwise defined in the text of this Agreement are defined in Section 9 hereof.